Pharmaceuticals
Company Overview of JB Therapeutics, Inc.
Executive Profile
Paul D. Goldenheim M.D.Advisor, JB Therapeutics, Inc. |
| Age | Total Calculated Compensation | This person is connected to 9 Board Members in 9 different organizations across 15 different industries. See Board Relationships |
| -- | -- |
Background
Dr. Paul D. Goldenheim, M.D., serves as Scientific Advisor of Edimer Pharmaceuticals Inc. Dr. Goldenheim serves as a Consultant in the field of biotechnology. He serves as an Advisor at JB Therapeutics, Inc. He has a 25-year history in pharmaceutical research, development, and management and served as the President of TransForm Pharmaceuticals Inc., from May 2004 to February 2006. Prior to joining TransForm, from 1985 to 2004, Dr. Goldenheim held multiple positions at ...
Corporate Headquarters508 Dudley RoadNewton Center, Massachusetts 02459 United States Phone: 617-413-3020 Fax: 617-795-2189 Board Members MembershipsVice Chairman Director Director Former Director Director Director Director Director Former Director Member of The Board of Directors Director 2006-2007 Former Independent Director, Member of Science Committee and Member of Compensation Committee 2010-Present Director
EducationBA Harvard College MD Harvard Medical School
Other Affiliations |
Annual CompensationThere is no Annual Compensation data available.Stocks OptionsThere is no Stock Options data available.Total CompensationThere is no Total Compensation data available. |
COMPETITOR COMPENSATION
| There is no Competitor Compensation data available. |
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- New Brunswick, NJ | Tridiagonal SolutionsPosted: Apr 24
- Austin, TX | Publicis Touchpoint SolutionsPosted: May 21
- Fairfax, VA | Clinical Review GroupPosted: May 20
Sponsored Financial Commentaries
Sponsored Links
To contact JB Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








